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Abstract
Objective:  To  establish  the  prevalence  of sensorineural  hearing  loss  (SNHL),  as  well  as  the
predisposing  risk  factors,  in  children  and  adolescents  with  type  1 diabetes  mellitus  (T1DM)
attending the  Service  of  Endocrino-Pediatrics  and Otolaryngology  Department  of  the ‘‘Dr.  José
Eleuterio González’’  University  Hospital  and  the  Materno-Infantil  Hospital,  from  January  2011
to December  2012.
Material  and methods: A  total  of  84  children  with  T1DM,  with  ages  between  6 and  18  years  old,
were studied.  Values  of  glycated  hemoglobin  (HbA1c)  were  assessed  and  Tonal  audiometry  and
Speech audiometry  tests  were  performed.
Results:  A  total  of  84  patients  with  a  diagnosis  of  T1DM  were  studied,  out  of  which  12  (14.3%)
presented  SNHL.  Fifty  percent  of  patients  with  hearing  loss  were  in  the  age range  of  10--13
years old.  Regarding  time  of  evolution  with  the  disease  (T1DM),  33%  of  patients  with  more  than
5 years  with  T1DM  presented  SNHL,  and nearly  88.9%  of  the  patients  with  less  than  5  years
with T1DM  presented  normal  hearing  (p  =  0.011).  Moreover,  65.47%  of  the patients  presented
complications  due  to  poor  glycemic  control  at some  point  in the evolution  of  their  disease.  All
(100%) diabetic  patients  with  SNHL  and 91%  of  the  patients  without  SNHL  had  HbA1c  values
greater than  6%.  In  patients  with  hearing  impairments,  83.3%  suffered  mild  and  16.4%  suffered
moderate hearing  loss.  Most  presented  bilateral  hearing  loss,  with  the  right  ear  dominating.
Acute frequencies,  mainly  8000  kHz,  were  the  most  affected.
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:Conclusion:  SNHL  prevalence  among  our  diabetic  population  was  14.3%,  which  indicates  that  a
sixth of  our  diabetic  type  1  population  will  develop  SNHL.  According  to  the  results  obtained,
SNHL is more  frequent  among  patients  who  have  had  T1DM  for  more  than  5 years.  Nevertheless,
more studies  are required  to  confirm  that there  is a  relation  between  time  spent  with  the  disease
and SNHL.
©  2015  Universidad  Autónoma  de Nuevo  León.  Published  by  Masson  Doyma  México  S.A.  This  is
an open  access  article  under  the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Introduction
The  World  Health  Organization  (WHO)  defines  diabetes
mellitus  (DM)  as  a  multiple-etiology  metabolic  disorder,
characterized  by  chronic  hyperglycemia  and  other  metabolic
abnormalities,  which  result  in  absolute  or  relative  insulin
deficiency.  It  is  the  most frequent  endocrine-metabolic  dis-
order  in  children  and  adolescents,  and  has  remained  the
main  type  of  diabetes  in children.1--4
Type  1 diabetes  mellitus  (T1DM)  is  a disease  with  an eti-
ology  of  intervening  environmental  factors  which  interact
with  a  genetic-predisposition  component;  it is considered  a
chronic  autoimmune  disease  which  causes  the  destruction
of  the  pancreatic    cells  which  produce  insulin.5
The  average  age of  the onset  of  the  disease  is  between  7
and  15  years  of  age;  however,  it may  occur  at any  age.6
Values  of the  HbA1c  > 6% higher  than  the normal  range
(5--6%) have  been  considered  a  risk  of developing  micro-  and
macroangiopatic  complications.  The  affection  of the blood
vessels  which  supply  the  inner  ear and  the  vascular  stria  have
been  reported  by  different  authors  as  a  physiopathological
cause  of  SNHL  in T1DM  patients.3,7 Treatment  with  insulin,
maintaining  on  average  HbA1c  of 7.2%,  reduces  the onset
and  progression  of  microangiopatic  complications,  atrophy,
and  demyelination  of the  spiral  ganglion  by  up  to  76%.8,9,13
Sensorineural  hearing  loss  (SNHL)  is  a loss  of hearing  at
any  frequency  more  than  25  dB,  with  conductive  and  sen-
sorineural  gaps  lower  that  20  dB,  and  affecting  the  patient’s
ability  to communicate,  his  or  her  education,  job  prospects
and  social  relationships,  and  also  causes  stigmatization.11,12
The  reported  prevalence  of SNHL  is  up  to  33%  in  children
with  T1DM  versus  0.3--0.5%  in healthy  children.  In  Mexico
there  is a lack  of  sufficient  epidemiologic  information  which
defines  the  hearing  condition  prevailing  in our  population.12
Materials  and  methods
A  prospective  longitudinal,  analytic,  comparative  study  was
conducted  on  a total  of  87  patients  of  both  sexes,  ages
6--18,  with  a  T1DM  diagnosis,  from  the Service  of  Endocrino-
Pediatrics  and Otolaryngology  Department  of the  ‘‘Dr.  José
Eleuterio  González’’  University  Hospital  and  the Materno-
Infantil  Hospital,  from  January  2011  to  December  2012.
We  included  patients  who  agreed  to participate  in the
protocol  through  a signed  informed  consent,  signed  by  their
parents  and/or  guardians  and/or  the patient.  We  excluded
patients  with noise  exposure,  a family  history  of  deafness,
use  of ototoxic  medications,  otitis  media,  a history  of
previous  ear  surgery  (except  ventilation  tube  insertion)  and
DM  type  2.
All  subjects  in  this  study  were  given  a  questionnaire,
which  included  family,  prenatal,  natal and  personal  patho-
logical  and  non-pathological  history. Patients  underwent
basic  otorhinolaryngological  exploration,  tone audiometry
and  oral  audiometry  using  an  audiometer  AUDIOTEST  259b,
manufactured  for Interacustics,  Type 2 Tone  Audiometer,
Type  B-E-T  speech  audiometer  in a soundproof  cabin  Acous-
tics  Systems,  Model  RE-142,  Serial  #21413a,  made  in USA.
The  study  was  approved  by the  Ethics  and Research  Commit-
tee  of  the  School  of  Medicine  of  the  Universidad  Autónoma
de Nuevo  León  (UANL  by  its  Spanish  acronym)  with  the reg-
istration  key  OT12-002.
The information  obtained  was  gathered  in a  database
using  Excel,  performing  statistical  analysis  using SPSS  20.0.
We  obtained  the  traditional  statistics  in  the quantitative
and  qualitative  variables,  looking  to  establish  differences
between  both  groups  through  hypothesis  tests  for  means  and
proportions,  to  establish  the absence  or  presence  of  associa-
tion  and  correlation  using  chi square,  Pearson  or  Spearman,
with  a  confidence  and  reliability  of 95%.
Results
Out  of  the 87  recruited  patients  with  a T1DM  diagnosis,  we
excluded  a  patient  with  a  history  of  chronic  otitis  media  of
the  right  ear,  one  with  otitis  media  with  bilateral  effusion
and  a patient  with  a  final  diagnosis  of  T2DM.  The  remaining
84  patients  were  divided  into  3  groups  based  on  age:  6--9,
10--13,  and  14--18 years  old.  We  observed  that  72  patients
with  a T1DM  diagnosis  showed  normal  hearing  while  12  T1DM
patients  showed  sensorineural  hearing  loss  (Fig.  1).
85.7
14.3
Norma l hearing
Sensorineural
hearing loss
Figure  1  Average  of patients  with  type  1  diabetes  with  normal
hearing  and  sensorineural  hearing  loss.
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Figure  2  Comparison  of  both  groups  by  age  range.
The  6--9  group  included  20  patients  (9  girls  and  11  boys)
with  diabetes  with  an evolution  time  of less than  5  years;  10
(50%)  subjects  presented  a history  of  previous  complications
like  ketoacidosis,  hyperglycemia  or  hypoglycemia,  2 (10%)
patients  had  HbA1c  <  6  and  18 HbA1c  > 6, and  1 (5%)  sub-
ject  presented  mild  SNHL  for  8000  kHz  thresholds.  The  10--13
group  included  a total  of 30  patients  (13  girls  and  17  boys);
29  (34.5%)  had had diabetes  mellitus  for  less  than  5  years  and
1  (1.21%)  for  over 5  years,  18  (21.4%)  patients  presented  a
history  of  ketoacidosis,  hypo- or  hyperglycemia,  29  (34.52%)
presented  HbA1c  > 6  and  1 (1.19%)  HbA1c  <  6;  mild  SNHL  was
displayed  in 3 (3.57%)  subjects  and 1  (1.19%)  patient  dis-
played  moderate  SNHL,  and  all 4  patients  were  in hearing
thresholds  of  8000  kHz.  The  14--18  group  consisted  of 34
patients  (40.47%)  (20 girls  and  14  boys),  22  (64.70%)  with
an  evolution  time  of  less  than  5 years  and  12  (35.29%)  for
more  than  5 years;  complications  like ketoacidosis,  hypo-
or  hyperglycemia  were  reported  by  27  of  them;  3  (8.82%)
subjects  showed  an HbA1c  < 6 and  31  (91.17%)  an  HbA1c  > 6;
SNHL occurred  within  this  group  in 7 individuals  (mild  in 6
and  moderate  in  1).  In  all  patients,  SNHL  was  observed  in
thresholds  of  8000  kHz  (See  Table  1).
In  our  study,  we  were  able  to  observe  a percentage  preva-
lence  of  SNHL of  14.3%  (12  out of  84  patients).  Also, 64
patients  (76.19%)  with  T1DM  were older  than  10  years  of
age,  as  opposed  to  a small group  of  20  patients  (23.80%)
between  the  ages  of  6 and  9 (Fig.  2).  There  were  no  differ-
ences  in  gender,  each  representing  50%.  In regard  to  time  of
evolution  of  T1DM,  15.47%  (13  patients)  with  over 5  years
with  T1DM  presented  SNHL,  and 84.52%  (71  patients)  with
less  than  5 years  with  T1DM  presented  normal  hearing,  this
being  a  statistically  significant  value  (p  =  0.011)  (Fig.  3).
66.70%
88.90%
33.30%
11.10%
0.00% 20.00% 40.00% 60.00% 80.00% 100.00 %
T1DM + SNH
T1DM +  normal hearing
T1DM = diabetes mellitus type 1; SNH = sensorineural hearing loss 
More than 5 years with T1DM 5 years or less with T1DM
Figure  3  Comparison  of  both  groups  by T1DM  evolution  time.
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Figure  4  Previous  complications  from  uncontrolled  blood  glu-
cose in  both  groups.
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Figure  5 Degrees  of  sensorineural  hearing  loss.
Out  of the 84  patients,  55  (64.47%)  presented
complications  at  some  point during  the evolution  of  their
disease  due  to  glycemic  irregularities;  the  most  frequent
complication  was  ketoacidosis  and  the least  prevalent  was
hypoglycemia  (Fig.  4).
In the  present  study,  100%  of  diabetic  patients  with  SNHL
(12  patients)  and  91%  of  patients  with  normal hearing  pre-
sented  HbA1c  values  greater  than  6%,  showing  an average
value  of 7.5%  in the  general  population  studied.  Accord-
ing  to  age groups,  the group  consisting  of  children  between
6  and  12  years  presented,  on  average,  an HbA1c  value  of
7.24%,  while  the group  consisting  of  children  between  13
and  19  years  of age  presented,  on  average,  an  HbA1c  value
of  7.67%.
Of  all  the SNHL  patients,  83.30%  (10  patients)  presented
mild  hearing  loss  and  16.70%  (2 patients)  moderate  hear-
ing  loss  (Fig.  5). Most patients  presented  bilateral  hearing
loss,  predominately  on  the right  ear. The  8000  kHz thresholds
were  the  most  affected.  (Table  1)
Discussion
An  SNHL  prevalence  of  up  to  33%  in children  with  T1DM
has  been  considered,  versus  0.3--0.5%  in healthy  children.
In  Mexico,  there  is  a  lack  of  epidemiologic  information  that
can  define  the hearing  condition  which  prevails  among  our
population.12
The  observed  prevalence  in  our  studied  group  was  14.3%,
contrary  to  the rate  reported  in different  publications.
However,  we  must  keep  in  mind  that  most  of  the studied
population  is  American  or  European.  It  is  important  to stress
the fact  that there  are  still  many  T1DM  cases  that  have
not  been  diagnosed,  but  with  the obtained  results  at this
point,  we  are able  to  infer  that up  to  a sixth  of  the diabetic
population  in  our  society  will  develop  SNHL.
Regarding  age,  the  obtained  information  matches  the one
found  in the  bibliography.  Most  children  are in the mentioned
peak  ranges,  especially  above  10 years  of age,  beginning
with  hormone  changes  that  are a  normal part of puberty  and
adolescence.  Nevertheless,  based  on  the obtained  results
we  are able  to see  that  the patient’s  age  does  not represent
a  risk  factor  for  the presence  of  SNHL.
According  to  the  American  Diabetes  Association  (ADA)
and  the  Diabetes  medical  attention  standards  of  2014,  the
goal  for  HbA1c  in type  1 diabetic  patients  varies  depend-
ing on  age.  Concerning  values  <8%  in the  6--12 years-of-age
range,  because  it is not possible  to  have  more  strict  goals
due  to  the  risk  of  developing  hypoglycemia,  even  in  this
age  range  we  can  demand  goals  of  <7.5%  in specific cases
where  patients  do  not  present  severe  hypoglycemia.  In the
13--19  years-of-age  range,  values  of  <7.5%  are considered
and  in specific  cases  even  <7%. In  children  under  6 years  of
age,  goals  of  <8%  are too  strict,  so  up  to  <8.5%  is  accept-
able,  because  these  children  have  a greater  vulnerability
for  hypoglycemia,  a greater  sensitivity  to  insulin,  and  are
unpredictable  in their  intake  and physical  activity.10
The  average  population  showed  HbA1c  values  of  7.5% and
taking  the results  by  age  group  into  account,  we  are  able  to
say  that  our patients,  under  13  years  of age  with  an  HbA1c
average  of  7.24%,  are within  an adequate  glycemic  control,
because  they  are  inside  the accepted  range  by  the ADA  2014
(6--12 years  = <8%);  and  patients  older than  13  years  of  age
with  an average  of  7.67%  show a  control  barely  above  that
expected  for their  age  group  (13--19  years  = <7.5%).
It is important  to  maintain  HbA1c  values  as  close  to
normal  as  possible,  thus  reducing  by almost  80%  the  risk
of  presenting  microangiopatic  complications;  however,  we
must  not  be very  strict  with  our  population,  especially  with
children  under  13  years  of  age,  because  of the risks  of  pre-
senting  severe  or  belated  hypoglycemia  cases,  and  hence
the  importance  of following  the standards  established  by
the  ADA 2014.
Regarding  time  of evolution  with  T1DM,  it  was  the  only
statistically  significant  risk  factor  (p  =  0.011)  for  a period
greater  than  5  years  and  the presence  of  hearing  loss.  How-
ever,  when  we  looked  for  the correlation  between  both
factors,  we  did not  find  it.  The  present  study  showed  a
greater  prevalence  of  hearing  loss  in patients  with  more
than  5  years  of  evolution  of  T1DM,  without  it being  asso-
ciated  or  related.  This  could  be due to  the  lack  of potency
in  the  studied  population  who  presented  T1DM  and  SNHL,
requiring  a  greater  number  of  patients  and  further  research.
Nevertheless,  it is  important  that  5  years  after  a  T1DM  diag-
nosis,  as  there  is  an already  established  protocol  in search  of
microangiopatic  complications  like  retinopathy,  we  estab-
lish  the  application  of  hearing  studies  which  allow  us to
detect  hearing  problems  in  a timely  manner.
Out  of  all  of  our  patients  with  SNHL,  83.3%  presented
a  mild  hearing  loss,  bilaterally,  in acute  frequencies,  pre-
dominately  8000  Hz,  which agrees  with  the rate  obtained
in  previous  studies.  The  type of  hearing  loss  presented
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in  these  patients  is  similar  to the  one that patients  with
presbycusis  would  present,  but  at an earlier age  compared
to  the  population  without  T1DM.
This  research  provided  valuable  data  to  lead  the  way
for  new  researches  in  these types  of  patients,  and  estab-
lish  a  timely  and  protocol-led  assessment  for  their  glycemic
control  as  well  as  their  hearing,  thus  avoiding  hearing
complications  which  patients  with  a  T1DM  of  long  duration
present,  like  SNHL  and  sudden  hearing  loss.  Also,  later  stud-
ies  are  recommended  where  a long-term  follow-up  is given
to  these  patients  in order  to  determine  the causation  degree
of  the  studied  risk  factors on the  base  pathology.
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